Atlas Trials

Phase Ib/IIa Clinical Study of ACC017 Tablets

Clinical trial NCT06719310 · COMPLETED

Trial details

NCT number
NCT06719310
Sponsor
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency Virus
Start date
2024-08-28
Primary completion
2025-04-28
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.